Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 258

The DOI matches its Crossref record.

Applications of carbonic anhydrase inhibitors and activators in therapy

Supuran, Claudiu T, Scozzafava, Andrea·2002·Expert Opinion on Therapeutic Patents

Abstract

Inhibitors and activators of the zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1) have a large number of applications in therapy. Many types of such new derivatives have been reported recently, together with their potential applications as antiglaucoma, anticancer and anti-osteoporosis agents or for the management of a variety of neurological disorders, among others. Furthermore, some CA isozymes seem to be valuable markers of tumour progression in a variety of tissues and organs. The CA activators, although not clinically exploited up to now, seem to constitute a new revolutionary approach for the treatment of Alzheimer's disease and other neurodegenerative disorders in need of memory therapy. Recent progress in all these areas, as well as in the characterisation of new such enzymes/isozymes isolated in many organisms/tissues and their detailed catalytic/inhibition mechanisms are, reviewed in the present paper.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1517/13543776.12.2.217

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 258

Metadata

Authors
Supuran, C. T., & Scozzafava, A.
Venue
Expert Opinion on Therapeutic Patents
Published
2002-02
Volume
12
Issue
2
Pages
217-242
ISSN
  • 1354-3776 (ISSN-L)
  • 1744-7674
OpenAlex
W2119482876
Cited by
258
References
0
FWCI
9.40
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Applications of carbonic anhydrase inhibitors and activators in therapy. https://app.cochat.ai/papers/10.1517/13543776.12.2.217
The paper
Supuran, C. T., & Scozzafava, A. (2002). Applications of carbonic anhydrase inhibitors and activators in therapy. Expert Opinion on Therapeutic Patents. https://doi.org/10.1517/13543776.12.2.217

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.